Data Sheet 6_Assessing the disease burden of lower respiratory infections attributable to particulate matter pollution: trends from 1990 to 2021 and projections for 2022-2050.pdf by Erman Wu (19021269)

“…</p>Results<p>In 2021, PMP was responsible for an estimated 651,238 (95% UI, 121,605-1076,503) deaths and 29,098,331(6,988,265-48,127,683) DALY from LRIs globally (ASMR: 8.68; ASDR: 420.09 per 100,000). Despite significant declines since 1990 (ASMR EAPC: -2.44%), profound disparities persisted. …”

Data Sheet 2_Assessing the disease burden of lower respiratory infections attributable to particulate matter pollution: trends from 1990 to 2021 and projections for 2022-2050.pdf by Erman Wu (19021269)

“…</p>Results<p>In 2021, PMP was responsible for an estimated 651,238 (95% UI, 121,605-1076,503) deaths and 29,098,331(6,988,265-48,127,683) DALY from LRIs globally (ASMR: 8.68; ASDR: 420.09 per 100,000). Despite significant declines since 1990 (ASMR EAPC: -2.44%), profound disparities persisted. …”

Data Sheet 10_Assessing the disease burden of lower respiratory infections attributable to particulate matter pollution: trends from 1990 to 2021 and projections for 2022-2050.pdf by Erman Wu (19021269)

“…</p>Results<p>In 2021, PMP was responsible for an estimated 651,238 (95% UI, 121,605-1076,503) deaths and 29,098,331(6,988,265-48,127,683) DALY from LRIs globally (ASMR: 8.68; ASDR: 420.09 per 100,000). Despite significant declines since 1990 (ASMR EAPC: -2.44%), profound disparities persisted. …”

Data Sheet 9_Assessing the disease burden of lower respiratory infections attributable to particulate matter pollution: trends from 1990 to 2021 and projections for 2022-2050.pdf by Erman Wu (19021269)

“…</p>Results<p>In 2021, PMP was responsible for an estimated 651,238 (95% UI, 121,605-1076,503) deaths and 29,098,331(6,988,265-48,127,683) DALY from LRIs globally (ASMR: 8.68; ASDR: 420.09 per 100,000). Despite significant declines since 1990 (ASMR EAPC: -2.44%), profound disparities persisted. …”

Data Sheet 4_Assessing the disease burden of lower respiratory infections attributable to particulate matter pollution: trends from 1990 to 2021 and projections for 2022-2050.pdf by Erman Wu (19021269)

“…</p>Results<p>In 2021, PMP was responsible for an estimated 651,238 (95% UI, 121,605-1076,503) deaths and 29,098,331(6,988,265-48,127,683) DALY from LRIs globally (ASMR: 8.68; ASDR: 420.09 per 100,000). Despite significant declines since 1990 (ASMR EAPC: -2.44%), profound disparities persisted. …”

Supplementary Material for: Focus on the Blind Spot of Stone Disease: Analysis of Lower Urinary Tract Stone Interventions from 2006 to 2020 using German nationwide inpatient data. by Herout R. (20352174)

“…Methods We analyzed data from the nationwide German hospital billing database from 2006 to 2020. The significance of changes over time was evaluated via linear regression analysis. …”

Trial design. by Llum Páez (22553360)

“…Vaccination against canine leishmaniasis intends to decrease the parasite burden and the risk of clinical disease. …”

Schedule of the trial. by Llum Páez (22553360)

“…Vaccination against canine leishmaniasis intends to decrease the parasite burden and the risk of clinical disease. …”

Clinical symptoms scoring system. by Llum Páez (22553360)

“…Vaccination against canine leishmaniasis intends to decrease the parasite burden and the risk of clinical disease. …”

Marketed vaccines against canine leishmaniasis. by Llum Páez (22553360)

“…Vaccination against canine leishmaniasis intends to decrease the parasite burden and the risk of clinical disease. …”

Various parameters characterizing Lb related to lung volume or alveolar surface before, during and after bulk alveolarization (adulthood). by Julia Hüttmann (22656283)

“…During alveolarization values remain constant. At pnd 21 a significant decrease compared to 3 days old pups is visible. …”

Characterization of Developmentally Dynamic Promoters (DDPs). by Jiang Tan (260415)

Sex- and age-related changes in individual variance and behavioural repeatability. by Andréa L. Johnson (22505376)

We compared the Fugl-Meyer (FMA) clinical assessment scores for individuals with stroke with their performance for each outcome measure. by Devin Sean Austin (20285144)

Renal outcomes of both treatment groups. by Marwan El-Deyarbi (21688492)

“…Participants in the multifactorial group achieved a significant mean difference in low-density lipoprotein cholesterol levels (mean difference = −0.14, 95% CI: −0.27–0.001, P < 0.03), and significant adjusted mean difference of eGFR levels difference (3.93 mL/min/1.73 m², 95% CI: 1.27–6.58, P < 0.01) at study completion compared to those in the control group. …”

Table 2_Predicting ventilator-associated lower respiratory tract infection outcomes using sequencing-based early microbiological response: a proof-of-concept prospective study.docx by Ji Zhou (481629)

“…Objectives<p>Ventilator-associated lower respiratory tract infections (VA-LRTIs) cause significant mortality. …”

Image 1_Predicting ventilator-associated lower respiratory tract infection outcomes using sequencing-based early microbiological response: a proof-of-concept prospective study.tif by Ji Zhou (481629)

“…Objectives<p>Ventilator-associated lower respiratory tract infections (VA-LRTIs) cause significant mortality. …”

Table 3_Predicting ventilator-associated lower respiratory tract infection outcomes using sequencing-based early microbiological response: a proof-of-concept prospective study.docx by Ji Zhou (481629)

“…Objectives<p>Ventilator-associated lower respiratory tract infections (VA-LRTIs) cause significant mortality. …”

Table 1_Predicting ventilator-associated lower respiratory tract infection outcomes using sequencing-based early microbiological response: a proof-of-concept prospective study.doc by Ji Zhou (481629)

“…Objectives<p>Ventilator-associated lower respiratory tract infections (VA-LRTIs) cause significant mortality. …”

Identifying optimal cluster numbers in hierarchical cluster analysis. by Dolores Bernenko (16528426)